Evidence map›Paper›PMID 41631395›Full record

ArticleImmunology and cell biology2026

The geometry of pMHC-coated nanoparticles and T-cell receptor clusters governs the sensitivity-specificity trade-off in T-cell response: a modeling investigation.

Louis Richez, Anmar Khadra

Abstract read
In one paragraph

Article in Immunology and cell biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Louis RichezDepartment of Physiology, McGill University, Montreal, QC, Canada.ORCID https://orcid.org/0000-0002-3895-9992
Anmar KhadraDepartment of Physiology, McGill University, Montreal, QC, Canada.ORCID https://orcid.org/0000-0002-8228-9914

Funding

Natural Sciences and Engineering Research Council of Canada RGPIN-2019-0452NSERC-CREATE Graduate Research Award
6 · The paper itself

Abstract

T cells must reliably discriminate between foreign-derived antigens that require an adaptive immune response and nonspecific self-antigens that do not. This discrimination is highly specific to the affinity of the bond between the ligand and T-cell receptors (TCRs), and highly sensitive to the concentration of ligand. We examined the features of T-cell-mediated immunity in the context of multivalent ligand-receptor interactions between clusters of TCRs with peptide major histocompatibility complex-coated nanoparticles (NPs). Using Monte Carlo simulations of NP-T-cell surface interactions, we compared the effect of TCR clustering on the dose-response curves of bound TCRs when various NP design parameters were altered. These simulations revealed a trade-off between sensitivity and specificity, mediated by TCR clustering and NP geometry. Large TCR clusters enhance sensitivity to both NP valence and NP concentration at the expense of antigen specificity. This loss of specificity arises from two key effects of TCR clustering on NP binding: (1) steric hindrance caused by TCR proximity and NP size, leading to early saturation of bound TCRs; and (2) increased the avidity of multivalent low-affinity NPs. The combination of saturated high-affinity binding and amplified low-affinity binding resulted in impaired affinity-based discrimination. Finally, we demonstrated how kinetic proofreading (KPR) mechanisms mediated by TCR phosphorylation were able to recover specificity in models of T-cell activation. Together, these results suggest that multivalent ligand-receptor interactions promote greater sensitivity at the expense of specificity, and provide mechanistic insights into early T-cell activation that can guide the design of NPs for therapeutic applications.

Indexed as

Histocompatibility AntigensMajor Histocompatibility ComplexModels, ImmunologicalNanoparticlesReceptors, Antigen, T-CellT-LymphocytesAnimalsHumansLigandsLymphocyte ActivationMonte Carlo MethodProtein BindingHistocompatibility AntigensLigandsReceptors, Antigen, T-Cellligand discriminationmultivalent bindingnanoparticlesreceptor clusteringT cellT‐cell receptors

Identifiers

PMID41631395
PMCPMC12972249

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.